5d
How Investors May Respond To Celcuity (CELC) Winning FDA Nod For Revtopik Amid Wider Quarterly Loss
In the second quarter of 2026, Celcuity Inc. reported a wider net loss of US$78.86 million and basic loss per share of ...
Amylyx Pharmaceuticals reported second-quarter 2026 results showing a net loss of US$43.42 million and basic loss per share ...
Beyond the markets, Santa Fe galleries celebrate modern pottery masters, Indigenous photography, and more. Galleries Featuring Native Artists ADOBE GALLERY 221 CANYON ROAD I 505-955-0550 I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results